Conditional Expression of Α1-Antitrypsin Delivered by Recombinant SV40 Vectors Protects Lymphocytes Against HIV

Gene Therapy - United Kingdom
doi 10.1038/sj.gt.3302113
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

SV40-derived Vectors Provide Effective Transgene Expression and Inhibition of HIV-1 Using Constitutive, Conditional,and Pol III Promoters

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2001English

Synthesis of Α1-Antichymotrypsin and Α1-Antitrypsin by Human Trophoblast

Pediatric Research
Child HealthPediatricsPerinatology
1993English

Correction To: Genetically Engineered Cell Lines for Α1-Antitrypsin Expression

Biotechnology Letters
Applied MicrobiologyBiotechnologyMedicineBioengineering
2018English

Α1-Antitrypsin (SERPINA1; AAT; A1AT)

Science-Business eXchange
2010English

Molecular Mechanism of Z Α1-Antitrypsin Deficiency

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2016English

Effect of Alpha-1 Antitrypsin Portland Variant (Α1-Pdx) on HIV-1 Replication

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2000English

Neue Strategien Zur Kontrollierten Inhalation Von Α1-Antitrypsin

Pneumologie
MedicinePulmonaryRespiratory Medicine
2003English

Metastability in the Inhibitory Mechanism of Human Α1-Antitrypsin

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1999English

Mage-B Vaccine Delivered by Recombinant Listeria Monocytogenes Is Highly Effective Against Breast Cancer Metastases

British Journal of Cancer
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy